How to use imaging endpoints reflecting the pulmonary circulation & RV

16 June 2025

Presented at PVRI's Drug Discovery & Development Symposium 2025, David Kiely, University of Sheffield

Summary

Imaging is essential in pulmonary hypertension, acting as a surrogate endpoint in clinical trials. It highlights the importance of right ventricular function and showcases various imaging techniques with predictive capabilities. CMR imaging stands out as a promising marker, while new technologies like perfusion imaging and hyper-polarised gases provide fresh insights. The integration of AI aims to improve clinical outcomes, emphasising the need for collaboration in future studies.


Generated with AI, edited by PVRI
Share:

Other materials on this topic

27 November 2025

Pulmonary Arterial Wedge Oxygen Saturation: Does It Confirm Wedge Position in Patients With Pulmonary Hypertension?

Pulmonary artery wedge pressure is a crucial measurement for differentiating between hemodynamic categories of pulmonary hypertension (PH), particularly Groups 1 and 2. In this prospective study, we analyzed the diagnostic utility of checking wedge oxygen saturation to confirm wedge position during right heart catheterization in patients referred for PH.

Pulmonary Circulation
30 October 2025

The Predictive Value of Quantitative Analysis of SPECT V/Q Imaging for Postoperative Persistent/Recurrent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy

Pulmonary endarterectomy (PEA) is a highly effective treatment for chronic thromboembolic pulmonary hypertension (CTEPH). However, persistent or recurrent pulmonary hypertension (persistent/recurrent PH) following surgery can adversely impact patients’ outcomes. 

Pulmonary Circulation